Blaine Templeman, Executive VP, General Counsel at ADURO BIOTECH, INC. (ADRO), sold 3,785 shares at $11.95 ($45K) on 2017-01-11, disclosed to the SEC on 2017-01-13.
Scheduled sale ($45k) by Executive VP, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| ADRO | SELL | 2019-12-16 | $1K | — | Filing → |
| ADRO | SELL | 2019-09-17 | $17K | — | Filing → |
| ADRO | SELL | 2018-12-14 | $4K | — | Filing → |